GPS Wealth Strategies Group’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
GPS Wealth Strategies Group's IBB Position: Q4 2025 in Review
GPS Wealth Strategies Group reduced its iShares Biotechnology ETF (IBB) stake by 18% in Q4 2025, selling an estimated $2.92K and leaving 84 shares worth $14.2K. The position accounts for 0.01% of the portfolio, ranked #351.
GPS Wealth Strategies Group first reported a position in IBB in Q1 2021 and has held it in 19 quarters since. The position peaked at $126K in Q4 2021. 958 funds tracked by Wall St. Rank hold IBB as of Q4 2025.
- GPS Wealth Strategies Group held 84 shares of iShares Biotechnology ETF worth $14.2K as of Q4 2025.
- GPS Wealth Strategies Group sold 18 iShares Biotechnology ETF shares in Q4 2025, an estimated $2.92K.
- iShares Biotechnology ETF made up 0.01% of GPS Wealth Strategies Group's portfolio in Q4 2025, its #351 holding.
- GPS Wealth Strategies Group first reported a position in iShares Biotechnology ETF in Q1 2021 and has held it in 19 quarters since.
- GPS Wealth Strategies Group's iShares Biotechnology ETF position peaked at $126K in Q4 2021.
- 958 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2025.
Based on GPS Wealth Strategies Group's 13F filing for Q4 2025, filed 6 Feb 2026.